The present invention relates to novel pyrrolopyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.

 
Web www.patentalert.com

< Myocardium conditioning using myocardial and parasympathetic stimulation

> Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood

> Cancer treatment with endothelin receptor antagonists
~ 00543